Recurrent Renal Pelvis Urothelial Carcinoma
5 clinical trials · Condition
◉ Watch Recurrent Renal Pelvis Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153) | National Cancer Institute (NCI) | 2022-07-07 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952) | National Cancer Institute (NCI) | 2019-06-05 |
| Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780) | National Cancer Institute (NCI) | 2018-07-20 |
| Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer (NCT00749892) | M.D. Anderson Cancer Center | 2008-06-10 |
Track Recurrent Renal Pelvis Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.